DarioHealth Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DRIO | HCAT | AMWL | OPRX | ALC.AX | NURS.V | |
|---|---|---|---|---|---|---|
| Market cap | 29.10M | 119.66M | 210.06M | 184.97M | 155.23M | 150.82M |
| P/E (TTM) | — | — | — | 40.9 | — | 21.6 |
| Forward P/E | -2.7 | 212.0 | -11.3 | 9.4 | 34.6 | 5.9 |
| Price/book | 0.4 | 1.2 | 1.0 | 1.4 | 1.7 | 3.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −75.41% | −46.28% | +178.77% | −51.30% | +15.38% | −38.74% |
| Today | −1.00% | +10.42% | −3.06% | +5.25% | +9.52% | −6.95% |
The closest companies by business and industry (Health Information Services). Prices may be delayed up to 20 min.
Latest news
All DRIO news ›Dario Expands Contract with a Leading Regional Grocery Retailer, Adding Women's Digital Health and Clinical Care Program
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the... Contract extension follows benefits realized from Dario's cardiometabolic…
Analyzing DarioHealth (NASDAQ:DRIO) and Firefly Neuroscience (NASDAQ:AIFF)
Posted by Sarita Garza on Oct 21st, 2026 DarioHealth (NASDAQ:DRIO – Get Free Report) and Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the…
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
The Manila Times ST. LOUIS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it wil
DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs
Oct 06, 2026, 07:30 ET A component study of the independent review by Aon found $5,077 in annual savings and 23.5% fewer inpatient discharges per Dario user with type 2 diabetes versus matched non-users Evaluation of 17 studies estimates…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- prnewswire.com3
- manilatimes.net1
- stocktitan.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.